美国垂体偶发瘤:基于国家数据库的估计
基于SEER 2020数据库分析2004至2018年美国垂体腺瘤与垂体偶发瘤的发病趋势,共纳入50,220例垂体腺瘤。垂体偶发瘤发病率从0.73/10万升至2.00/10万,占垂体腺瘤比例从24.91%升至42.07%,女性及微腺瘤更常见。
要点
- 2004至2018年垂体偶发瘤发病率从0.73/10万升至2.00/10万,增长近3倍。
- 垂体偶发瘤占所有垂体腺瘤的比例从24.91%升至42.07%(P < 0.001)。
- 垂体偶发瘤中女性占64.72%,微腺瘤占61.68%,均高于非偶发瘤垂体腺瘤。
核心结论
- 美国垂体腺瘤报告增多可能由垂体偶发瘤诊断增加所致,该结果与其他国家发现一致。
- 该全国性垂体偶发瘤估计值可作为未来研究各机构影像检查率和垂体偶发瘤率的比较基准。
研究设计与样本
- 从SEER 2020提交数据中选取50,220例垂体腺瘤,筛选出无需初始手术或药物治疗的垂体偶发瘤。
- 分析年龄调整发病率、患者人口学特征、肿瘤特征、时间趋势及垂体腺瘤与垂体偶发瘤的差异。
主要发现
- 2004至2018年垂体腺瘤和垂体偶发瘤的年龄调整发病率分别为4.28 ± 0.04和1.53 ± 0.02每10万人。
- 垂体偶发瘤发病率从2004年的0.73 ± 0.05每10万人增至2018年的2.00 ± 0.09每10万人,增长近3倍。
- 垂体偶发瘤占所有垂体腺瘤诊断的比例从2004年的24.91%显著增至2018年的42.07%(P < 0.001)。
- 与非偶发瘤垂体腺瘤相比,垂体偶发瘤更常见于女性(64.72% vs. 54.27%;P < 0.001)和微腺瘤(61.68% vs. 13.37%;P < 0.001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Increasing use of imaging is associated with increasing diagnoses of pituitary incidentalomas (PIs), which often do not require surgical or medical treatment. In this study, we evaluate U.S. incidence, epidemiology, and trends of pituitary adenomas (PAs) and PIs from 2004 to 2018. METHODS: A total of 50,220 PAs were selected from the SEER (Surveillance Epidemiology and End Results) 2020 submission. PIs that do not initially require surgical or medical treatment were filtered from PAs if they were best diagnostically confirmed by radiography, not indicated as prolactinomas in physician reports, not recommended surgery initially, and reported a correct tumor size. Age-adjusted incidence rates, patient demographics, tumor characteristics, trends over time, and differences between PAs and PIs were explored. RESULTS: Between 2004 and 2018, the incidence rates of PAs and PIs were 4.28 ± 0.04 and 1.53 ± 0.02 per 100,000 population, respectively. When observing changes from 2004 to 2018, a nearly 3-fold increase from 0.73 ± 0.05 to 2.00 ± 0.09 per 100,000 was observed for PIs. The proportion of PIs significantly increased from 24.91% of all PA diagnoses in 2004 to 42.07% in 2018 (P < 0.001). When comparing non-PI PAs with PIs, PIs were more commonly diagnosed in females (64.72% vs. 54.27%; P < 0.001) with microadenomas (61.68% vs. 13.37%; P < 0.001). CONCLUSIONS: Reports of increasing PAs in the United States are likely caused by an increase in diagnosing PIs. This result parallels findings from other countries. This national PI estimate may serve as a point of comparison for future studies investigating imaging and PI rates at individual institutions.
引用
- Watanabe G, Choi SY, Adamson DC, et al. Pituitary Incidentalomas in the United States: A National Database Estimate. World Neurosurg. 2021. PMID: 34838770. doi:10.1016/j.wneu.2021.11.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。